Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Carroll

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Tropical Medicine and Hygiene|June 1, 1994
A prospective investigation of the long-term auditory-neurological sequelae associated with bacterial meningitis: a study from VanuatuK J Carroll, C Carroll
Clinical Pharmacology and Therapeutics|April 3, 2016
Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trialE Burmeister Getz, K J Carroll, B Jones, et al.
European Journal of Public Health|January 7, 2021
Shiga toxin-producing Escherichia coli diagnosed by Stx PCR: assessing the public health risk of non-O157 strainsK J Carroll, C Jenkins, L Harvey-Vince, et al.
Clinical Pharmacology and Therapeutics|October 12, 2016
Between-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical TrialE Burmeister Getz, K J Carroll, J Mielke, et al.
Blood|October 15, 1994
Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cellsF C Zeigler, B D Bennett, C T Jordan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Tropical Medicine and Hygiene|June 1, 1994
A prospective investigation of the long-term auditory-neurological sequelae associated with bacterial meningitis: a study from VanuatuK J Carroll, C Carroll
Clinical Pharmacology and Therapeutics|April 3, 2016
Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trialE Burmeister Getz, K J Carroll, B Jones, et al.
European Journal of Public Health|January 7, 2021
Shiga toxin-producing Escherichia coli diagnosed by Stx PCR: assessing the public health risk of non-O157 strainsK J Carroll, C Jenkins, L Harvey-Vince, et al.
Clinical Pharmacology and Therapeutics|October 12, 2016
Between-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical TrialE Burmeister Getz, K J Carroll, J Mielke, et al.
Blood|October 15, 1994
Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cellsF C Zeigler, B D Bennett, C T Jordan, et al.
Pageof 1